Cell Therapy Manufacturing

Optimizing cell therapy workflows is critical to achieving robust, repeatable, and cost-effective manufacturing while supporting consistent product quality, safety, and efficacy. From early process development to commercial-scale production, manufacturers face challenges including variability in patient-derived cells, contamination risks from manual and open operations, and difficulties scaling while meeting stringent regulatory requirements.

Thermo Fisher Scientific addresses these challenges with closed, automated, and modular solutions designed to support flexible, scalable cell therapy manufacturing across autologous and allogeneic workflows.

Browse products   Contact a specialist

Key benefits include:

• Lower contamination risk—Closed, automated processes reduce manual handling and microbial exposure, helping ensure safety and sterility.
• Consistent quality—standardized workflows enable batch-to-batch reliability and support regulatory compliance.
• Flexible and scalable design—modular systems allow seamless integration of advanced tools and efficient scaling without major system overhauls.
• Cost-efficient operations—automation minimizes labor, errors, and cleanroom requirements while maximizing capital efficiency.
• Space-saving footprint—compact, modular designs reduce cleanroom space and maintenance burden.
• Real-time digital control—integrated, 21 CFR part 11–compliant software enables live instrument monitoring, traceability, and process optimization.

Together with cGMP-compliant Gibco CTS media and reagents, including PeproGMP cytokines, these solutions support optimized, closed workflows tailored to your cell therapy process needs—helping you transition efficiently from preclinical development to clinical and commercial manufacturing.

Product characterization is crucial in cell therapy manufacturing to help ensure innovative therapies reach patients safely. Analytical testing of cell therapies faces challenges due to the complexity and variability of living cell products, limited sample availability, and the need for rapid safety testing. Conventional assays often involve complex manual steps, longer turnaround times, and lack of standardization. At Thermo Fisher Scientific, we offer a comprehensive range of ready-to-use tests and automation-compatible workflows to help you achieve your stringent quality standards, no matter the starting material. Streamline your current workflow with our analytical solutions to meet quality and purity standards.

Discover the advancements in automation and innovative manufacturing processes to accelerate cell therapy commercialization. Hear from specialists as they share insights, challenges, and successes in implementing flexible, scalable, and automated solutions.